This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Now, researchers at the Broad Institute and the National Emerging Infectious Diseases Laboratories (NEIDL) at Boston University have used an image-based screening method developed at the Broad to identify human genes that, when silenced, impair the Ebola virus’s ability to infect. AI gave us an unprecedented ability to do this at scale."
By leveraging combined expertise in reagent innovation and laboratory automation, these alliances develop versatile platforms that optimise library preparation processes and lower the risk of human error. 12 This partnership enables laboratories to process up to 96 samples concurrently while cutting hands-on time by nearly 7.5
Our approach, grounded in Good Laboratory Practice (GLP) and honed through thousands of studies, ensures that even the most subtle toxicological indicators are reliably detected. Sompura, Method Development Team Lead at Sannova Analytical, brings over 18 years of experience in the Bioanalytical Laboratory Department.
Promising areas for AI implementation When discussing the most transformative AI applications in drug discovery, Sujeegar identifies a particularly ambitious goal: developing AI models that can simulate human pharmacokinetics and pharmacodynamics (PK/PD) using only preliminary laboratory data.
The research appears today in Nature Methods. Collaborating models Many existing protein prediction models can only make predictions based on the protein and cell data on which they were trained or are unable to pinpoint a proteins location within a single cell.
& Researchers at the Broad Institute and The Jackson Laboratory have used prime editing, a precise and versatile form of gene editing, to correct the root cause of AHC in mice. There is no cure or effective treatment for this rare genetic disease, but new research suggests a potential path to one.&
Patient recruitment and clinical laboratory and diagnostic services are the top drug development activities likely to be outsourced, similar to previous reports. FSP outsourcing is growing faster than full-service outsourcing , across both large and small/mid-size biopharma segments.
The integration of machine learning enables the team to predict which novel proteins are most likely to play critical roles in disease – all before any laboratory work begins. This approach accelerates discovery by focusing experimental efforts where the data suggests the highest potential impact.
Previous clinical and laboratory studies on other MCL1 inhibitors have suggested that these molecules can impair heart cells, likely because of prolonged exposure to the compounds. The compound inhibited the growth of a broad range of cancer models, including breast cancer, lung cancer, melanoma, sarcoma, lymphoma, and leukemia.
Knowledge of metabolic control in bacteria is not only important for practical applications in biotechnology , medicine, and the environmental sciences but is also a foundation for fundamental research in laboratories across the globe. Measurement of bacterial growth based on optical density (OD 600 ) is frequently used in many laboratories.
For good laboratory practice (GLP) studies, project teams may consider freezing select tissue blocks for MSI under a non-GLP protocol. He went on to complete postdoctoral studies in Professor Gary Keck’s laboratory at the University of Utah, where he investigated mechanisms of stereoselective reactions.
Its AI platforms are designed specifically for CGT, capable of handling complex biological data, integrating with laboratory and manufacturing systems, and adapting to evolving research and clinical needs. These solutions were designed for standardised processes and fail to manage the dynamic, high-variability data unique to living therapies.
Dr. Joerg Koglin, senior vice president and head of general and specialty medicine at Merck Research Laboratories, echoed this sentiment, stressing the broad potential impact of the therapy. “To We thank all study participants for being part of this important study.”
In the rapidly evolving landscape of life sciences, the communication gap between laboratory scientists and data scientists remains a significant challenge. However, they recognised that data science and AI were becoming increasingly important, not only within laboratories but also within automation.
Sygnature Discovery, a leading integrated drug discovery contract research organisation (CRO), today announces the completion of a major enhancement to its high-throughput chemistry (HTC) capabilities and laboratory infrastructure following a £1 million investment.
Optimizing Tube Labeling for Improved Efficiency The tube labeling process starts with the generation of an Excel file generated from our Laboratory Information Management System (LIMS), which contains a list of unique IDs and sample information. This file is then imported into an MS App interface to create the user request.
Dr. Marjorie Green, Senior Vice President and Head of Oncology Global Clinical Development at Merck Research Laboratories, emphasized the significance of this new trial within the broader scope of the ADC’s development.
Guide for the Care and Use of Laboratory Animals. NIH Office of Laboratory Animal Welfare – Training Guidelines. Alternatives to Laboratory Animals , 50(3). Federal ruling on USDA primate welfare petition, 2023. National Research Council. European Directive 2010/63/EU on the protection of animals used for scientific purposes.
With Bio-Techne’s global distribution network and integrated analytical platforms like the MauriceFlex™, more laboratories can now seamlessly adopt these standards into their workflows.
In the rapidly evolving landscape of life sciences, the communication gap between laboratory scientists and data scientists remains a significant challenge. This represents another skill we’re asking laboratory scientists to develop. This ‘silo problem’ can impede innovation and slow down research progress.
SRP-001 has already moved beyond the laboratory. Bazan sees it as part of a broader shift towards combination therapies – an approach that will likely define the next generation of pain management. From bench to bedside: what is next?
Furthermore, QIAGEN will validate the diagnostic panel’s performance and robustness, ensuring its utility across a range of laboratory settings. This diagnostic panel will aid clinicians in guiding their treatment decisions by identifying the patients most likely to respond to Incyte’s innovative therapy.
Based on a technology developed by Broad Institute core member David Liu’s laboratory, the treatment is the first in a series of new medicines being tested to treat rare diseases by repairing patients’ particular genetic misspellings. The team that treated K.J.
Clinical research generates vast amounts of diverse data from laboratory tests, patients, medical equipment, and outside sources. By organising and analysing this information, researchers can extract actionable insights that improve patient outcomes, data accuracy, drug efficacy and speed up trials.
By bringing research and clinical development under one organizational roof, Alnylam aims to accelerate its ability to turn laboratory discoveries into life-saving treatments.
Using patient-centered strategies and data analytics, our capabilities cover multiple therapeutic areas and include early development, all phases of clinical development, peri- and post-approval, novel approaches to patient recruitment and investigator sites and comprehensive laboratory services. Get in touch.
The two companies have signed a Memorandum of Understanding (MoU) to provide comprehensive support and resources to Japanese drug-discovery startups, helping them bring their innovations from laboratory benches toward eventual global delivery of new medicines.
What makes this an exciting time is that laboratory automation technology has matured significantly in recent years. When predictions concern biology which is inherently complex it takes time to cultivate cells and can be expensive to generate sufficient data. These two halves of the problem are coming together.
Since their initial development, both base editing and prime editing have been used by thousands of laboratories around the world and have enabled the study and potential treatment of many genetic diseases. The Breakthrough Prize is one of the worlds most important science awards.
Their three state-of-the-art bioanalytical laboratories feature mirrored operations and uniform protocols to maintain consistency and quality across client projects, ensuring reliable, high-quality data regardless of location. Whether for preclinical or clinical studies, we provide tailored solutions to meet specific research needs.
Presenter Lennart Nickel, Doctoral Assistant in the Laboratory of Protein Design & Immunoengineering at EPFL. Bindcraft Workshop By Rose Circeo June 4, 2025 Breadcrumb Home Bindcraft Workshop November 6, 2025 12:00-4:00 pm Workshop (lunch served) 4:00-5:00 pm Broad Institute museum tour Registration opens June 9.
Jayaprakash Kotha, MBBS, PhD, ASCP (SH), Vice President, Bioanalytical Laboratory Satish Kumar, MBB, Head of Process Improvement Continuous Innovation is a Cornerstone of Bioanalysis Approximately 80% of drugs that begin the research process fail to reach approval. What is one contributing factor that sets the 20% that do apart from the rest?
The I-TEAM Hub is a laboratory space specifically designed for FDA staff to have hands-on experience with various advanced technologies on which they would advise, e.g., AI/machine learning, 3D printing, etc. To support this, the Innovative Technologies and Advanced Manufacturing Hub (I-TEAM Hub) was created.
Li, President of Merck Research Laboratories, underscored the importance of this approval for the company’s pediatric infectious disease portfolio. Additional safety data are expected to be collected as ENFLONSIA is introduced into broader clinical use. A New Era in Infant RSV Protection Dr. Dean Y.
We have state-of-the-art, purpose-built laboratories at our locations in the U.S. Following clear processes, in accordance with GLP and current FDA/EMA guidelines—and supported by our unique array of platforms and large list of validated assays —our team ensures the most effective methods for your individual programs.
This simplicity in dosing may help streamline clinical workflows and facilitate broader use in outpatient, hospital, and community health settings. Dr. Richard M.
His areas of expertise include protein and nucleic acid sample preparation, mass spectrometry, proteomics, glycomics, analytical chemistry, and laboratory equipment sales. Throughout his career, he has accumulated experience in sales and product management within the life science sector.
Working at the famed Pasteur Institute, the duo began by figuring out how best to culture mycobacteria — a seemingly simple, but essential first step, given how no one at the time had yet come up with an effective way of growing these bacteria in the laboratory. Many more could emerge as machine learning tools improve.
In her current role, Kaylyn assists PCR scientists with their projects and helps them identify tools and craft custom laboratory solutions to meet sponsors’ needs. ABOUT THE AUTHOR: KAYLN KOENIG Kaylyn Koenig first joined Altasciences in 2019 as a scientist and was promoted to Principal Scientist in 2023.
The goal is to transform laboratory discoveries into clinically relevant therapies that can reach patients faster and more efficiently. Meanwhile, research into neurology and rare diseases continues to be an area of unmet need where innovative science can deliver transformative solutions.
ALTASCIENCES’ FLOW CYTOMETRY SERVICES Our clinical facilities at Altasciences are integrated with state-of-the-art flow cytometry laboratories. We are all pushing the boundaries in terms of technology while acknowledging the importance of guidelines to ensure scientific reliability.
Digital Tools: Is your protocol designed for remote care realities, such as remote monitoring, diagnostics, and laboratory logistics? Are they available in the correct language(s)? Are they written to meet patient comprehension levels?
With airlocks around the manufacturing and laboratory areas, staff could safely gown and de-gown. These isolated suites feature containment systems for negative pressure controls to limit exposure, and for monitoring and verifying effectiveness of the containment strategies.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content